MicroRNA (miRNA) Market Report: Trends, Forecast and Competitive Analysis
In Progress. Get it in 2 to 4 weeks by ordering today
The future of the microRNA (miRNA) market looks promising with opportunities in cancer, infectious dieseases, immunological disorders, cardiovascular dieseases, and neurological dieseases applications. The global microRNA (miRNA) market is expected to grow with a CAGR of 17%-19% from 2020 to 2025. The major drivers for this market are advancements in analytical methods that enable accurate detection & quantification of miRNAs and investments in research activities for identification of miRNAs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global microRNA (miRNA) market report, please download the report brochure.
In this market, products is the largest research tool segment of microRNA (miRNA), whereas academic & government research institutes is the largest end user. Growth in various segments of the microRNA (miRNA)market are given below:
The study includes trends and forecast for the global microRNA (miRNA) market by research tool, application, end user, and region as follows:
By Research Tool [Value ($ Million) shipment analysis for 2014 – 2025]:
ServicesSample collectionWhole BloodSerumPlasmamiRNA cDNA SynthesisProfiling & PurificationDetectionFunctional StudiesNGSMicroarrayReal Time PCROthersProductsInstrumentsConsumablesIsolation & PurificationQuantification & DetectionFunctional AnalysisOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
CancerInfectious DieseasessImmunological DisordersCardiovascular DieseasesNeurological DieseasesOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology and Pharmaceutical CompaniesAcademic & Government Research InstitutesOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the microRNA (miRNA) companies profiled in this report include Thermofisher Scientific, Agilent Technologies, Merck, QIAGEN, and NanoString Technologies.
Lucintel forecasts that consumables will remain the largest segment over the forecast period due to higher adoption of functional studies to investigate the role of different miRNAs and increase in advanced studies with help of highly sophisticated equipment such as NGS and qRT-PCR.
Within this market, academic & government research institutes will remain the largest end user segment over the forecast period due to rapid adoption of microRNA research tool by universities and research labs and adoption of research tools in translation of scientific knowledge to clinical applications.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due presence of strong technical support and well-established research infrastructure in genomics, proteomics, oncology, and advanced diagnostic research, rapid progress in genomic studies.
Features of the Global MicroRNA (miRNA) Market
Market Size Estimates: Global microRNA (miRNA) market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global microRNA (miRNA) market size by various segments, such as research tool, application, and end user in terms of value.Regional Analysis: Global microRNA (miRNA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different research tool, application, end user, and region for the global microRNA (miRNA) market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global microRNA (miRNA) market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global microRNA (miRNA) market by research tool (services (sample collection (whole blood, serum, and plasma), miRNA cDNA synthesis, profiling & purification, detection, and functional studies (NGS, microarray, real time PCR, and others), and products (instruments and consumables (isolation & purification, quantification & detection, functional analysis, and others)), application (cancer, infectious dieseasess, immunological disorders, cardiovascular dieseases, neurological dieseases, and others), end user (biotechnology and pharmaceutical companies, academic & government research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global microRNA (miRNA) market?
Q.5 What are the business risks and threats to the global microRNA (miRNA) market?
Q.6 What are the emerging trends in this microRNA (miRNA) market and the reasons behind them?
Q.7 What are some changing demands of customers in this microRNA (miRNA) market?
Q.8 What are the new developments in this microRNA (miRNA) market? Which companies are leading these developments?
Q.9 Who are the major players in this microRNA (miRNA) market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this microRNA (miRNA) market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global microRNA (miRNA) market?
The future of the microRNA (miRNA) market looks promising with opportunities in cancer, infectious dieseases, immunological disorders, cardiovascular dieseases, and neurological dieseases applications. The global microRNA (miRNA) market is expected to grow with a CAGR of 17%-19% from 2020 to 2025. The major drivers for this market are advancements in analytical methods that enable accurate detection & quantification of miRNAs and investments in research activities for identification of miRNAs.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global microRNA (miRNA) market report, please download the report brochure.
In this market, products is the largest research tool segment of microRNA (miRNA), whereas academic & government research institutes is the largest end user. Growth in various segments of the microRNA (miRNA)market are given below:
The study includes trends and forecast for the global microRNA (miRNA) market by research tool, application, end user, and region as follows:
By Research Tool [Value ($ Million) shipment analysis for 2014 – 2025]:
ServicesSample collectionWhole BloodSerumPlasmamiRNA cDNA SynthesisProfiling & PurificationDetectionFunctional StudiesNGSMicroarrayReal Time PCROthersProductsInstrumentsConsumablesIsolation & PurificationQuantification & DetectionFunctional AnalysisOthers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
CancerInfectious DieseasessImmunological DisordersCardiovascular DieseasesNeurological DieseasesOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology and Pharmaceutical CompaniesAcademic & Government Research InstitutesOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the microRNA (miRNA) companies profiled in this report include Thermofisher Scientific, Agilent Technologies, Merck, QIAGEN, and NanoString Technologies.
Lucintel forecasts that consumables will remain the largest segment over the forecast period due to higher adoption of functional studies to investigate the role of different miRNAs and increase in advanced studies with help of highly sophisticated equipment such as NGS and qRT-PCR.
Within this market, academic & government research institutes will remain the largest end user segment over the forecast period due to rapid adoption of microRNA research tool by universities and research labs and adoption of research tools in translation of scientific knowledge to clinical applications.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due presence of strong technical support and well-established research infrastructure in genomics, proteomics, oncology, and advanced diagnostic research, rapid progress in genomic studies.
Features of the Global MicroRNA (miRNA) Market
Market Size Estimates: Global microRNA (miRNA) market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global microRNA (miRNA) market size by various segments, such as research tool, application, and end user in terms of value.Regional Analysis: Global microRNA (miRNA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different research tool, application, end user, and region for the global microRNA (miRNA) market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global microRNA (miRNA) market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global microRNA (miRNA) market by research tool (services (sample collection (whole blood, serum, and plasma), miRNA cDNA synthesis, profiling & purification, detection, and functional studies (NGS, microarray, real time PCR, and others), and products (instruments and consumables (isolation & purification, quantification & detection, functional analysis, and others)), application (cancer, infectious dieseasess, immunological disorders, cardiovascular dieseases, neurological dieseases, and others), end user (biotechnology and pharmaceutical companies, academic & government research institutes, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global microRNA (miRNA) market?
Q.5 What are the business risks and threats to the global microRNA (miRNA) market?
Q.6 What are the emerging trends in this microRNA (miRNA) market and the reasons behind them?
Q.7 What are some changing demands of customers in this microRNA (miRNA) market?
Q.8 What are the new developments in this microRNA (miRNA) market? Which companies are leading these developments?
Q.9 Who are the major players in this microRNA (miRNA) market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this microRNA (miRNA) market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global microRNA (miRNA) market?
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global MicroRNA (miRNA) Market Trends and Forecast
3.3: Global MicroRNA (miRNA) Market by Research Tool
3.3.1: Services
3.3.1.1: Sample collection
3.3.1.1.1: Whole Blood
3.3.1.1.2: Serum
3.3.1.1.3: Plasma
3.3.1.2: miRNA cDNA Synthesis
3.3.1.3: Profiling & Purification
3.3.1.4: Detection
3.3.1.5: Functional Studies
3.3.1.5.1: NGS
3.3.1.5.2: Microarray
3.3.1.5.3: Real Time PCR
3.3.1.5.4: Others
3.3.2: Products
3.3.2.1: Instruments
3.3.2.2: Consumables
3.3.2.2.1: Isolation & Purification
3.3.2.2.2: Quantification & Detection
3.3.2.2.3: Functional Analysis
3.3.2.2.4: Others
3.4: Global MicroRNA (miRNA) Market by Application
3.4.1: Cancer
3.4.2: Infectious Dieseasess
3.4.3: Immunological Disorders
3.4.4: Cardiovascular Dieseases
3.4.5: Neurological Dieseases
3.4.6: Others
3.5: Global MicroRNA (miRNA) Market by End User
3.5.1: Biotechnology and Pharmaceutical Companies
3.5.2: Academic & Government Research Institutes
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global MicroRNA (miRNA) Market by Region
4.2: North American MicroRNA (miRNA) Market
4.2.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.2.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.2.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.2.4: The United States MicroRNA (miRNA) Market
4.2.5: The Canadian MicroRNA (miRNA) Market
4.2.6: The Mexican MicroRNA (miRNA) Market
4.3: European MicroRNA (miRNA) Market
4.3.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.3.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.3.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.3.4: The United Kingdom MicroRNA (miRNA) Market
4.3.5: The Spanish MicroRNA (miRNA) Market
4.3.6: The German MicroRNA (miRNA) Market
4.3.7: The French MicroRNA (miRNA) Market
4.4: APAC MicroRNA (miRNA) Market
4.4.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.4.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.4.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.4.4: The Chinese MicroRNA (miRNA) Market
4.4.5: The Indian MicroRNA (miRNA) Market
4.4.6: The Japanese MicroRNA (miRNA) Market
4.5: ROW MicroRNA (miRNA) Market
4.5.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.5.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.5.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.5.4: Brazilian MicroRNA (miRNA) Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global MicroRNA (miRNA) Market by Research Tool
7.1.2: Growth Opportunities for the Global MicroRNA (miRNA) Market by Application
7.1.3: Growth Opportunities for the Global MicroRNA (miRNA) Market by End User
7.1.4: Growth Opportunities for the Global MicroRNA (miRNA) Market by Region
7.2: Emerging Trends in the Global MicroRNA (miRNA) Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global MicroRNA (miRNA) Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MicroRNA (miRNA) Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Thermofisher Scientific
8.2: Agilent Technologies
8.3: Merck
8.4: QIAGEN
8.5: NanoString Technologies
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global MicroRNA (miRNA) Market Trends and Forecast
3.3: Global MicroRNA (miRNA) Market by Research Tool
3.3.1: Services
3.3.1.1: Sample collection
3.3.1.1.1: Whole Blood
3.3.1.1.2: Serum
3.3.1.1.3: Plasma
3.3.1.2: miRNA cDNA Synthesis
3.3.1.3: Profiling & Purification
3.3.1.4: Detection
3.3.1.5: Functional Studies
3.3.1.5.1: NGS
3.3.1.5.2: Microarray
3.3.1.5.3: Real Time PCR
3.3.1.5.4: Others
3.3.2: Products
3.3.2.1: Instruments
3.3.2.2: Consumables
3.3.2.2.1: Isolation & Purification
3.3.2.2.2: Quantification & Detection
3.3.2.2.3: Functional Analysis
3.3.2.2.4: Others
3.4: Global MicroRNA (miRNA) Market by Application
3.4.1: Cancer
3.4.2: Infectious Dieseasess
3.4.3: Immunological Disorders
3.4.4: Cardiovascular Dieseases
3.4.5: Neurological Dieseases
3.4.6: Others
3.5: Global MicroRNA (miRNA) Market by End User
3.5.1: Biotechnology and Pharmaceutical Companies
3.5.2: Academic & Government Research Institutes
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global MicroRNA (miRNA) Market by Region
4.2: North American MicroRNA (miRNA) Market
4.2.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.2.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.2.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.2.4: The United States MicroRNA (miRNA) Market
4.2.5: The Canadian MicroRNA (miRNA) Market
4.2.6: The Mexican MicroRNA (miRNA) Market
4.3: European MicroRNA (miRNA) Market
4.3.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.3.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.3.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.3.4: The United Kingdom MicroRNA (miRNA) Market
4.3.5: The Spanish MicroRNA (miRNA) Market
4.3.6: The German MicroRNA (miRNA) Market
4.3.7: The French MicroRNA (miRNA) Market
4.4: APAC MicroRNA (miRNA) Market
4.4.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.4.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.4.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.4.4: The Chinese MicroRNA (miRNA) Market
4.4.5: The Indian MicroRNA (miRNA) Market
4.4.6: The Japanese MicroRNA (miRNA) Market
4.5: ROW MicroRNA (miRNA) Market
4.5.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.5.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.5.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.5.4: Brazilian MicroRNA (miRNA) Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global MicroRNA (miRNA) Market by Research Tool
7.1.2: Growth Opportunities for the Global MicroRNA (miRNA) Market by Application
7.1.3: Growth Opportunities for the Global MicroRNA (miRNA) Market by End User
7.1.4: Growth Opportunities for the Global MicroRNA (miRNA) Market by Region
7.2: Emerging Trends in the Global MicroRNA (miRNA) Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global MicroRNA (miRNA) Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MicroRNA (miRNA) Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Thermofisher Scientific
8.2: Agilent Technologies
8.3: Merck
8.4: QIAGEN
8.5: NanoString Technologies
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
